Literature DB >> 30935215

Prevalence and Severity of Neuropsychiatric Symptoms in Early- Versus Late-Onset Alzheimer's Disease.

Sarah Baillon1,2, Amy Gasper1, Frances Wilson-Morkeh1, Megan Pritchard3,4, Amala Jesu2, Latha Velayudhan1,3,4.   

Abstract

BACKGROUND: The study aimed to compare neuropsychiatric symptoms (NPS) in people with early-onset Alzheimer's disease (EOAD) and late-onset AD (LOAD).
METHODS: Fifty-six participants with LOAD and 24 participants with EOAD having mild dementia were assessed for NPS for their frequency, severity, and caregiver distress as measured by Neuropsychiatry Inventory (NPI) along with assessments of cognition and functional dependence.
RESULTS: Participants with EOAD and LOAD were not significantly different for total NPI score (P = .057). Early-onset Alzheimer disease had greater prevalence of all the NPS except apathy. Participants with EOAD were significantly worse on anxiety (P = .03), irritability (P = .01), and sleep (P < .01) subscales and their carers significantly more distressed by their irritability (P = .002) and sleeping patterns (P = .005). Regression analysis showed that higher NPI score was associated with longer duration of illness in EOAD and higher functional dependence in LOAD.
CONCLUSIONS: The NPS severity was similar between EOAD and LOAD although EOAD had higher symptom prevalence and carer distress.

Entities:  

Keywords:  Alzheimer’s disease; Neuropsychiatry Inventory; caregiver stress; early-onset Alzheimer’s disease; neuropsychiatric symptoms

Mesh:

Year:  2019        PMID: 30935215     DOI: 10.1177/1533317519841191

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  12 in total

Review 1.  Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia.

Authors:  Ramon Cacabelos
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

2.  Association of Neurofibrillary Tangle Distribution With Age at Onset-Related Clinical Heterogeneity in Alzheimer Disease: An Autopsy Study.

Authors:  Denis S Smirnov; David P Salmon; Douglas Galasko; Vanessa S Goodwill; Lawrence A Hansen; Yu Zhao; Steven D Edland; Gabriel C Léger; Guerry M Peavy; Diane M Jacobs; Robert Rissman; Donald P Pizzo; Annie Hiniker
Journal:  Neurology       Date:  2021-11-22       Impact factor: 9.910

3.  Brain Mitochondrial Dysfunction: A Possible Mechanism Links Early Life Anxiety to Alzheimer's Disease in Later Life.

Authors:  Qixue Wang; Mengna Lu; Xinyu Zhu; Xinyi Gu; Ting Zhang; Chenyi Xia; Li Yang; Ying Xu; Mingmei Zhou
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

4.  The severity of neuropsychiatric symptoms is higher in early-onset than late-onset Alzheimer's disease.

Authors:  Neus Falgàs; Isabel E Allen; Salvatore Spina; Harli Grant; Stefanie D Piña Escudero; Jennifer Merrilees; Rosalie Gearhart; Howard J Rosen; Joel H Kramer; William W Seeley; Thomas C Neylan; Bruce L Miller; Gil D Rabinovici; Lea T Grinberg; Christine M Walsh
Journal:  Eur J Neurol       Date:  2021-12-20       Impact factor: 6.288

5.  Deepen into sleep and wake patterns across Alzheimer's disease phenotypes.

Authors:  Neus Falgàs; Christine M Walsh; Thomas C Neylan; Lea T Grinberg
Journal:  Alzheimers Dement       Date:  2021-03-12       Impact factor: 16.655

Review 6.  Anxiety and depression in Alzheimer's disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline.

Authors:  Rossana Botto; Nicoletta Callai; Aurora Cermelli; Lorenzo Causarano; Innocenzo Rainero
Journal:  Neurol Sci       Date:  2022-04-23       Impact factor: 3.830

Review 7.  Is Sleep Disruption a Cause or Consequence of Alzheimer's Disease? Reviewing Its Possible Role as a Biomarker.

Authors:  Maria-Angeles Lloret; Ana Cervera-Ferri; Mariana Nepomuceno; Paloma Monllor; Daniel Esteve; Ana Lloret
Journal:  Int J Mol Sci       Date:  2020-02-10       Impact factor: 5.923

Review 8.  The Relationship Between Anxiety and Alzheimer's Disease.

Authors:  Mario F Menddez
Journal:  J Alzheimers Dis Rep       Date:  2021-03-08

9.  Comorbidity between Alzheimer's disease and major depression: a behavioural and transcriptomic characterization study in mice.

Authors:  Ana Martín-Sánchez; Janet Piñero; Lara Nonell; Magdalena Arnal; Elena M Ribe; Alejo Nevado-Holgado; Simon Lovestone; Ferran Sanz; Laura I Furlong; Olga Valverde
Journal:  Alzheimers Res Ther       Date:  2021-04-02       Impact factor: 6.982

10.  Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer's Disease.

Authors:  Ramón Cacabelos; Juan C Carril; Lola Corzo; Lucía Fernández-Novoa; Rocío Pego; Natalia Cacabelos; Pablo Cacabelos; Margarita Alcaraz; Iván Tellado; Vinogran Naidoo
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.